Health Professional Survey

France

France

Data analysis considers a panel of 50 general practitioners, 26 cardiologists, and 11 nutritionists from all regions of France.

Findings are summarized below:

General practitioners are very concerned with dyslipidemia among their patients because they are the only doctors who treat them throughout all stages of the disease, either initial or chronic. They do, however, consider CARDIOSMILE as an option for patients with no serious risks.

CARDIOSMILE fits well in the prescription logic of general GPs and specialists who are looking for a product which has no side effects and is easy to take. This approach is evident in the intentions of doctors from all three specialties, who unanimously begin treatment with healthy lifestyle changes plus CARDIOSMILE. However, CARDIOSMILE only comes as third choice among cardiologists (while statins come first).

Nutritionists claim that they would recommend CARDIOSMILE as first choice in their prescriptions.

This means that CARDIOSMILE has proved to have a strong projected market share for treating early dyslipidemias among the three medical specialties. It is a particularly interesting option when the drop in LDL is linked to its action on triglycerides and HDL.

The study concludes that 51% of doctors declare that they are ready to prescribe the product and 30% are waiting for samples and tests.

(*) Cardiosmile, private studies.

Lab test

Chile

Chile

Data analysis considers a panel of 21 doctors of the following specialties: 7 cardiologists, 4 internists, 4 nutriologists, 3 endocrinologists, and 3 gynecologists, in representation of Chilean specialists.

Findings are summarized below:

Doctors who treat more patients with cholesterol levels are cardiologists, internists, and nutriologists. Most specialists choose drug therapy as first-line treatment, and the great protagonists are statins. They are seldom combined with other drugs or treatments.

Nutriologists are the specialists who make greatest use of plant sterols in their treatments.

Nutriologists are the specialists who make greatest use of plant sterols in their treatments.

Most specialists know about plant sterols and have prescribed them, or still do, but only in certain cases. It is worth noting that they favor plant sterols over Benecol (yogurt with added plant stanols).

Most specialists know about CARDIOSMILE, either from sales reps or congresses. Frequent prescribers report positive experience (mostly nutriologists).

Seminars, courses, symposiums, and congresses organized by labs are well received. There is also considerable interest in attending medical refresher courses.

Nutriologists are the most receptive and open to using CARDIOSMILE as monotherapy and complement.

The recommendation is to position CARDIOSMILE’s benefits as complement for drug therapy with statins, mostly among cardiologists and internists.

(*) Cardiosmile, private studies.

Lab test

Do you want to know more?

Do you want more information about CARDIOSMILE product technology & applications, clinical studies (research agreements or support in the formulation or development of a clinical study of interest), or how to be our business partner in your country to co-create the new health paradigm? Then send us a message and we'll contact you as soon as possible.